Entia Biosciences, Inc.: 10-K filed 2014-03-31
What Entia Biosciences, Inc. reported in its annual report filed 2014-03-31 (fiscal FY 2013): 30 published measures, 62 facts as tagged in accession 0001469709-14-000106.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-03-31
- Fiscal period
- fiscal FY 2013
- Accession
- 0001469709-14-000106 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Entia Biosciences, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 631,094 | USD | |
| At 2012-12-31 | 462,969 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 1,580,681 | USD | |
| At 2012-12-31 | 1,111,262 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | -949,587 | USD | |
| At 2012-12-31 | -648,293 | USD | |
| At 2011-12-31 | -259,752 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 36,886 | USD | |
| At 2012-12-31 | 13,081 | USD | |
| At 2011-12-31 | 16,639 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -3,104,827 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -1,264,148 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -766,733 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -314,595 | USD | 366 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 314,746 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 369,273 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 855,142 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 374,364 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -64,604 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -63,327 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | -8,520,351 | USD | |
| At 2012-12-31 | -5,327,924 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 7,533,540 | shares | 365 |
| 2012-01-01 to 2012-12-31 | 7,298,579 | shares | 366 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 62,145 | USD | |
| At 2012-12-31 | 35,627 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -2,970,020 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -1,080,684 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 225,451 | USD | |
| At 2012-12-31 | 244,236 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 1,580,681 | USD | |
| At 2012-12-31 | 1,109,157 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 343,498 | USD | |
| At 2012-12-31 | 183,106 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 11,197 | USD | |
| At 2012-12-31 | 62,397 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 3,153,643 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 1,342,492 | USD | 366 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 138,941 | USD | |
| At 2012-12-31 | 132,133 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 183,623 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 261,808 | USD | 366 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 27,804 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 58,101 | USD | 366 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 7,793,760 | USD | |
| At 2012-12-31 | 5,115,587 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 126,227 | USD | |
| At 2012-12-31 | 78,321 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 64,082 | USD | |
| At 2012-12-31 | 42,694 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 0 | USD | |
| At 2012-12-31 | 0 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -3,213,827 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -1,285,548 | USD | 366 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 1,626,873 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 865,092 | USD | 366 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 18,312 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 25,327 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -30,725 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -26,124 | USD | 366 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -15,808 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 17,954 | USD | 366 |
Inspect the source
- Entity
- Entia Biosciences, Inc. / CIK 0001408299
- Captured
- SEC response SHA-256
87eeafe4cf9625d2111221a4c2dc5d771c0e1669a38f86f588b6abe3fa046262
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001408299.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))